|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 |
| (11) | Number of the document | 3057616 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14854535.3 |
| Date of filing the European patent application | 2014-10-16 | |
| (97) | Date of publication of the European application | 2016-08-24 |
| (45) | Date of publication and mention of the grant of the patent | 2020-03-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/060810 |
| Date | 2014-10-16 |
| (87) | Number | WO 2015/057910 |
| Date | 2015-04-23 |
| (30) | Number | Date | Country code |
| 201361891485 P | 2013-10-16 | US |
| (72) |
CINI, John, US
NAGI, Athena, US
TADDEI, Maria, US
|
| (73) |
Outlook Therapeutics, Inc.,
7 Clarke Drive, Cranbury, NJ 08512,
US
|
| (54) | BUFFER FORMULATIONS FOR ENHANCED ANTIBODY STABILITY |
| BUFFER FORMULATIONS FOR ENHANCED ANTIBODY STABILITY |